secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odyssey Therapeutics, Inc. (ODTX)
CIK:        0001882782
Form:       8-K
Filed at:   2026-05-11T20:30:18+00:00
Accession:  0001193125-26-216899
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Odyssey Therapeutics raises $25M from TPG affiliate in private placement concurrent with IPO at $18/share
--------------------------------------------------------------------------------

- Private placement of 1,388,889 shares of common stock at $18.00 per share for total proceeds of $25,000,002.
- Placement closed concurrently with the IPO on May 11, 2026; shares are registrable under existing Investor Rights Agreement.
- J.P. Morgan, TD Securities, Cantor Fitzgerald, Wedbush, Oppenheimer acted as placement agents; fee of 7% of purchase price.
- Company filed amended certificate of incorporation and bylaws effective upon IPO closing on May 11, 2026.
- TPG LSI Rise Orazio II, L.P., an affiliate of an existing stockholder, is the purchaser.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1882782/000119312526216899/0001193125-26-216899-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1882782/000119312526216899/odtx-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-216899

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer